Related Experiment Video
Updated: Dec 27, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Management and outcomes of pediatric septic thrombophlebitis: a case series
Jenny Koo1, Alice Pong1,2, Christopher Dory3
1Department of Pediatrics, UC San Diego, La Jolla, California, USA.
Insights
Pediatric septic thrombophlebitis treatment often involves prolonged antibiotics and anticoagulation. Many patients achieve infection resolution, but thrombosis may persist, suggesting potential for shorter treatment durations.
Area of Science:
- Pediatric Hematology
- Infectious Diseases
- Vascular Medicine
Background:
- Septic thrombophlebitis is a severe condition requiring specialized management.
- Pediatric hematologists play a key role in guiding anticoagulation strategies.
Purpose of the Study:
- To evaluate treatment outcomes for pediatric septic thrombophlebitis.
- To assess the effectiveness of combined antibiotic and anticoagulation therapy.
Main Methods:
- Retrospective, single-center study of hospitalized pediatric patients.
- Analysis of 28 patients treated for septic thrombophlebitis over ten years.
- Primary outcome: resolution of thrombophlebitis.
Main Results:
- 57% of patients (16/28) showed resolution of thrombosis.
- Most patients received both antibiotic and anticoagulation therapy.
- Median antibiotic duration: 65 days; median anticoagulation: 92 days.
- Low risk of infection relapse even with early treatment discontinuation.
Conclusions:
- Combined antibiotic and anticoagulation therapy is standard for pediatric septic thrombophlebitis.
- Thrombosis resolution rates were moderate, with a low risk of infection relapse.
- Further research is warranted to optimize treatment durations.
Abstract:
Septic thrombophlebitis is a potentially life-threatening condition. Pediatric hematologists are often consulted to provide recommendations regarding anticoagulation management. We conducted a ten-year retrospective, single-center study of hospitalized pediatric patients who were treated for septic thrombophlebitis. Our primary outcome was resolution of thrombophlebitis. Twenty-eight patients were included in the study. Eighty-nine percent of patients received both antibiotic and anticoagulation therapy. The median durations of intravenous and total antibiotic therapy were 47.5 days (range 14-120) and 65 days (range 14-281), respectively, and median duration of anticoagulation therapy was 92 days (range 41-268). Resolution of thrombosis defined by magnetic resonance imaging, computed tomography, or ultrasound imaging was documented in 16 of 28 (57%) patients. Despite the high rate of persistent thrombosis, there was a low risk of relapse of infection in cases where antibiotic and/or anticoagulation was discontinued prior to complete resolution of the thrombus. Further research is needed to determine if duration of antibiotic and/or anticoagulation treatment can be shortened.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Pulmonary Embolism III: Nursing Management